The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acq - P2P | Acquired

Total Raised




About SteadyMed Therapeutics

SteadyMed Therapeutics is a drug delivery therapeutics company engaged in the development for commercialization of its prefilled, size efficient and disposable PatchPump technology. The company's range of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner.

SteadyMed Therapeutics Headquarter Location

2410 Camino Ramon Suite 350

San Ramon, California, 94583,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SteadyMed Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SteadyMed Therapeutics is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

SteadyMed Therapeutics Patents

SteadyMed Therapeutics has filed 23 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Medical equipment
patents chart

Application Date

Grant Date


Related Topics




Dosage forms, Drug delivery devices, Vascular diseases, Prostaglandins, Hypertension


Application Date


Grant Date



Related Topics

Dosage forms, Drug delivery devices, Vascular diseases, Prostaglandins, Hypertension



Latest SteadyMed Therapeutics News

Wearable Injectors Market Industry Forecast Value & Future Scope 2026

Sep 15, 2021

Wearable Injectors Market Industry Forecast Value & Future Scope 2026 Wearable Injectors market players – SteadyMed Therapeutics, Inc., Enable Injections, UNILIFE CORPORATION, Insulet Corporation, among others represent the global Wearable Injectors market. The market study depicts an extensive analysis of all the players running in the  Wearable Injectors market  report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Wearable Injectors market report. Future Market Insights, in its latest business report, elaborates on the current situation of the global Wearable Injectors market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects. Understanding the Impact of Covid-19 on Healthcare Industry With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance. The FMI’s latest report on the Wearable Injectors market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic. Request For Table Of Content @ Report Highlights: Changing market dynamics in the industry In-depth market segmentation Recent industry trends and developments Competitive landscape Potential and niche segments, geographical regions exhibiting promising growth A neutral perspective on market performance Must-have information for market players to sustain and enhance their market footprint. Wearable Injectors Market: Segmentation On-body (adhesive patch) Disposable Spring-Based Oncology Hospitals Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Rest of Western Europe) Eastern Europe (Russia, Poland, Rest of Eastern Europe) Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand, Rest of Asia Pacific Excluding Japan) Japan Any Queries, Contact Us @ Critical Questions Answered in the Report What are ongoing trends that will shape market growth curve for global Wearable Injectors market? What are the drivers and challenges affecting the Wearable Injectors market demand? What are the recent technological advancement in the Wearable Injectors market? What are key trends and opportunities that will prevail the revenue growth of Wearable Injectors market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the Wearable Injectors market? Reasons to Buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. Why Future Market Insights? Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the Wearable Injectors market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape About FMI Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Jumeirah Lakes Towers, Dubai, For Media Enquiries: is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.8.2.1 You are leaving Disclaimer: You are now leaving website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the website and will be redirected to another site. These sites are not under the control of is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue

  • Where is SteadyMed Therapeutics's headquarters?

    SteadyMed Therapeutics's headquarters is located at 2410 Camino Ramon, San Ramon.

  • What is SteadyMed Therapeutics's latest funding round?

    SteadyMed Therapeutics's latest funding round is Acq - P2P.

  • How much did SteadyMed Therapeutics raise?

    SteadyMed Therapeutics raised a total of $35M.

  • Who are the investors of SteadyMed Therapeutics?

    Investors of SteadyMed Therapeutics include United Therapeutics, Square 1 Bank, Samson Venture Partners and KB Partners.

  • Who are SteadyMed Therapeutics's competitors?

    Competitors of SteadyMed Therapeutics include ALung Technologies, Corassist Cardiovascular, BioWave, CeQur, Relievant Medsystems and 14 more.

You May Also Like

Relievant Medsystems Logo
Relievant Medsystems

Relievant provides the underserved population with a low-risk therapy that can eliminate back pain while preserving other therapeutic options. The Company's Intracept System is a minimally invasive procedure that uses radiofrequency energy delivered through a small access tube into the vertebral body to ablate the Basivertebral nerve. The nerve, thought to significantly contribute to chronic low back pain, can no longer generate pain signals following ablation. The company was founded in 2004 and is based in Minneapolis, Minnesota.


Trigemina is focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products. Trigemina's lead product candidate, TI-001, is a patented new application of oxytocin. TI-001 has shown promising results for use as a safe and effective therapy for all forms of chronic and subacute head pain.

Facet Solutions

Facet Solutions has developed a total replacement for the facet joint to treat back pain from hypertrophy.


AllTranz aims to provide relief from chronic pain to patients outside the hospital setting.

BioWave Logo

BioWave is a neuromodulation pain therapy company whose major goal is to help physicians, physical therapists and athletic trainers manage their patients' or athletes pain and reduce or eliminate the use of opiates, NSAIDs and their associated side effects. Biowave devices deliver a therapeutic electrical signal into deep tissue in the body blocking the transmission of pain.

CeQur Logo

CeQur is developing and commercializing advanced yet simple-to-use insulin delivery devices that make it easier for people living with type 2 diabetes to adhere to therapy and stay in control of their disease. The Company's fully optimized device, PaQ, is a three-day, wearable device that provides freedom from multiple daily insulin injections.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.